RUGGERI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 2.866
EU - Europa 2.623
AS - Asia 431
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 5.930
Nazione #
US - Stati Uniti d'America 2.862
IE - Irlanda 664
SE - Svezia 651
IT - Italia 482
CN - Cina 371
DE - Germania 267
UA - Ucraina 248
FI - Finlandia 106
PL - Polonia 84
GB - Regno Unito 50
IN - India 42
BE - Belgio 23
FR - Francia 19
VN - Vietnam 13
PT - Portogallo 9
RU - Federazione Russa 7
CA - Canada 4
CH - Svizzera 3
EU - Europa 3
AT - Austria 2
CL - Cile 2
IR - Iran 2
MT - Malta 2
NO - Norvegia 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
IL - Israele 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 5.930
Città #
Dublin 664
Chandler 546
Jacksonville 532
Nyköping 354
Ashburn 191
Beijing 175
Dearborn 144
Princeton 131
Medford 118
Ann Arbor 108
Cambridge 103
Bremen 95
Des Moines 89
Messina 89
Warsaw 84
Boardman 50
Wilmington 34
Jinan 33
Pune 33
Rome 26
Shenyang 26
Woodbridge 25
Brussels 23
Nanjing 15
San Mateo 15
Dong Ket 13
Hebei 12
Milan 12
Zhengzhou 12
Tianjin 11
Bologna 10
Falls Church 10
New York 10
Ningbo 9
Norwalk 9
Seattle 9
Hangzhou 8
Lancaster 8
Taizhou 8
Taiyuan 7
Auburn Hills 6
Bari 6
Catania 6
Changsha 6
Helsinki 6
Houston 6
Jiaxing 6
Los Angeles 6
Pirri 6
Washington 6
Canicattì 5
Fuzhou 5
Mineo 5
Nanchang 5
Padova 5
Turin 5
Beja 4
Cagliari 4
Genoa 4
Hyderabad 4
Mumbai 4
Naples 4
San Giuliano Terme 4
Torino 4
Amadora 3
Capannori 3
Fairfield 3
Francavilla Al Mare 3
Grandate 3
Guangzhou 3
Kemerovo 3
Kunming 3
Lappeenranta 3
Leawood 3
Lesignano de' Bagni 3
Lucca 3
Monza 3
Napoli 3
Redwood City 3
Speyer 3
Wuhan 3
Zumpano 3
Ardabil 2
Augusta 2
Bisceglie 2
Castelfranco di Sotto 2
Chengdu 2
Copertino 2
Fort Worth 2
Genzano Di Roma 2
Haikou 2
Hefei 2
Ischia 2
Izano 2
Lanzhou 2
Las Vegas 2
Lasa 2
Lierna 2
Lima 2
London 2
Totale 4.063
Nome #
Lipomatosi simmetrica benigna (Madelung’s disease, sindrome di Launois-Bensaude) con interessamento mediastino e trachea a “fodero di sciabola”in un paziente con BPCO in fase avanzata 161
Il six-minute walking test quale predittore di desaturazioni ossiemoglobiniche notturne in soggetti BPCO normossiemici a riposo 98
Tiroidite di Hashimoto e sarcoidosi: nuove prospettive. 92
Molecular links between COPD and lung cancer: new targets for drug discovery? 79
Home Care in pazienti con insufficienza respiratoria cronica: risultati di un anno di esperienza nella provincia di Messina 72
BONE'S ATLAS MEDICINA POLMONARE 72
Fatal pneumomediastinum in COPD and interstitial lung fibrosis associated with use of non invasive mechanical ventilation 71
Hereditary hyperhomocysteinemia associated with nephrotic syndrome complicated by artery thrombosis and chronic thromboembolic pulmonary hypertension: A case report 69
Polmonite interstiziale fibrosante da amiodarone 68
Un caso di istiocitosi polmonare a cellule di Langerhans con sindrome nefrosica 65
Functional role of inflammasome activation in a subset of obese nonsmoking patients with severe asthma 64
A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD 63
Pneumomediastino spontaneo seguente all'ingestione di cibo in un ragazzo 63
Tosse…. per amore dei gatti ? 63
Role of Stem Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Pulmonary Emphysema 62
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 62
Bullous emphysema as first presentation of Ehlers-Danlos syndrome in monozygotic twins 61
Fatal pneumomediastinum associated with use of noninvasive mechanical ventilation 60
Food-exercise-induced anaphylaxis in a boy successfully desensitized to cow milk. 60
Tiroidite di Hashimoto e sarcoidosi: nuove prospettive 60
Lipomatosi simmetrica benigna e sindrome delle apnee ostruttive notturne: descrizione di un caso clinico e revisione della letteratura 60
Ruolo delle comorbidità nella Broncopneumopatia Cronica Ostruttiva (BPCO) in fase di riacutizzazione 60
Oral immunotherapy for egg allergy: a double-blind placebo-controlled study, with postdesensitization follow-up 59
Specific Oral Tollerence Induction With A Weekly Updosing Schedule in Children With Ige Mediated Cow's Milk Allergy 58
Lipomatosi simmetrica benigna (Medelung's disease, Sindrome di Lanunois-Bensaude) con interessamento mediastinico e trachea a “fodero di sciabola” in un paziente con BPCO in fase avanzata. 58
Alternative Methods for Assensing Bronchodilator Reversibilità in Chronic Obstructive Pulmonary Disease 58
Pneumatocele post-traumatico: a proposito di un caso a localizzazione multipla bilaterale 58
Oral immunotherapy for cow's milk allergy with a weekly updosing regimen: a randomized double blind controlled study. 58
Un caso di caverna tubercolare complicata da carcinoma a cellule squamose: uno sguardo endoscopico 57
Alterazioni nutrizionali e funzionali in pazienti con BPCO 56
Un singolare caso di tubercolosi miliare tisiogena con interessamento oculare bilaterale 56
Autoimmunity and COPD: Clinical Implications 56
Un caso di pneumatocele postraumatico a localizzazione multipla bilaterale 56
BPCO: terapia cortisonica nei pazienti diabeticiLa difficile riacutizzazione bronchitica di Andrea 55
Anxiety Affects the Perceived Level of Asthma Control Evaluated by Asthma Control Test 55
Home care for patients with chronic respiratory disorders: one year experience in a Sicily province 54
6-min walking test: a predictor of nocturnal hypoxaemia in normoxic patients with COPD 54
Bacterial agents of community-acquired lower respiratory tract infections: observational study on antimicrobial drugs susceptibility 54
Monitoraggio dell’ossido nitrico nell’aria espirata in paziente con sarcoidosi polmonare 54
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 54
Malattie Professionali del polmone 53
The CREATE project without parietaria pollen: can it be true? 53
TIOTROPIUM (T) AND FLUTICASONE/SALMETEROL COMBINATION (FSC) DO NOT CAUSE OXYGEN DESATURATION IN COPD 53
Associazione tra sindrome metabolica e sindrome delle apnee ostruttive del sonno 53
Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment 53
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 53
BPCO: un approccio multidimensionale 52
Value of exhaled nitric oxide in the evaluation of disease activity in sarcoidosis patients 52
A case of tuberculous cavity complicated with squamous cell carcinoma: an endoscopic view 51
Community acquired pneumonia in elderly people: aetiology and antimicrobial drug susceptibility 51
Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study 51
Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD 51
Successful management of acute respiratory failure with noninvasive mechanical ventilation after drowning, in an epileptic-patient 50
An unusual cause of chest pain 50
Bacterial agents of community acquired pneumonia and antimicrobial drugs susceptibility in elderly people. 49
Pneumomediastino spontaneo seguente all'ingestione di cibo in un ragazzo. 49
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 49
Home care for patients with chronic respiratory disorders: one year experience in a Sicily province 48
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine 48
Sleep Disorders Breathing in COPD Patients: Relationships between Awake and Nocturbal Parameters. 47
Role of the mucins in pathogenesis of COPD: implications for therapy 47
Changes in the spectrum of bacterial agents of community-acquired lower respiratory tract infections in hospitalized patients 46
Monitoraggio dell'ossido nitrico nell'aria espirata in pazienti con sarcoidosi polmonare. 46
Fatal pneumomediastinuminCOPDandinterstitiallungfibrosisassociatedwithuseofnoninvasivemechanicalventilation 46
Emergenze respiratorie nelle malattie neurologiche 46
Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease 46
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 46
Prevalenza di asma, rinite ed eczema atopico in età scolare in diverse aree di Messina 45
Late-onset Pompe disease (LOPD): Correlations between respiratory muscles CT and MRI features and pulmonary function 45
Transcription inhibitors and inflammatory cell activity 45
Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study 45
Il six-minute walking test quale predittore di desaturazioni ossiemoglobiniche notturne in soggetti BPCO normossiemici a riposo. 44
Sublingual immunotherapy: adherence based on timing and monitoring control visits 44
Infezioni delle basse vie respiratorie: studio osservazionale sull'eziologia e sulla resistenza batterica nella provincia di Messina 43
D-dimer value in the diagnosis of pulmonary embolism — May it exclude only? 43
Modello di monitoraggio non invasivo della sarcoidosi polmonare 43
Le Pneumopatie da fattori ambientali 42
Metodi alternativi nella valutazione della broncoreversibilità in pazienti affetti da BPCO 42
Prevalence of asthma; rhinitis; and atopic eczema in schoolchildren living in different areas of Messina: findings from a five years survey. 42
Sleep Disorders Breathing in COPD Patients: Relationships between Awake and Nocturbal Parameters 42
Cytomegalovirus pneumonia in patients with inflammatory bowel disease: a systematic review. 42
Bronchite cronica, BPCO ed enfisema 41
Polmoniti aquisite in comunità nella popolazione anziana: eziologia e suscettibilità antimicrobica 41
Direct Drug Provocation Test for the Diagnosis of Self-Reported, Mild and Immediate Drug Hypersensitivity Reaction in Children and Adolescents: Our Real-Life Experience 41
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 40
Breathing Pattern and Central Ventilatory Drive in Late-Onset Pompe Disease 40
FORMA LIMITATA DELLA GRANULOMATOSI DI WEGNER: DIFFICOLTÀ DIAGNOSTICHE. 39
Qualità di vita come indice di efficacia globale nel trattamento della BPCO - Inteventi farmacologici. Revisione/Evidenze della Letteratura 39
Interferonopathy: A potential link between innate immunity and autoimmunity in the pathogenesis of COPD 39
Le Malformazioni polmonari congenite 38
Community acquired pneumonia in elderly people: aetiology and antimicrobial drug susceptibility. 38
A case of fibrosing interstitial pneumonia 38
null 37
Comparison of the impacts of tiotropium (T) and fluticasone/salmeterol combination (FSC) on arterial blood gases (ABGs) in patients with stable COPD. 37
Clinical effects of adding fluticasone propionate/salmeterol (FSC) and tiotropium (TIO) in severe-to-very severe COPD. 37
Value of exhaled nitric oxide in the evaluation of disease activity in sarcoidosis Patients. 37
Strategie per la diagnosi precoce del carcinoma polmonare 37
Exhaled nitric oxide as tool of non invasive assessment of pulmonary sarcoidosis. 36
Post-intensive care unit respiratory failure in older patients: Can we predict intensive care unit discharge properly? 36
Diabete e apparato respiratorio. Associazione diabete-BPCO 35
Totale 5.267
Categoria #
all - tutte 22.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201914 0 0 0 0 0 0 0 0 0 0 0 14
2019/20201.022 152 71 8 51 11 149 136 96 30 115 183 20
2020/2021868 104 23 157 49 59 96 22 127 36 101 46 48
2021/2022962 10 129 6 38 18 12 62 48 25 107 228 279
2022/20232.090 144 155 89 172 239 209 20 107 862 7 60 26
2023/2024529 46 79 19 70 69 147 13 23 7 19 22 15
Totale 6.110